Immunotherapy is a type of cancer treatment that uses the power of a person’s immune system to fight their cancer. Instead of directly attacking cancer cells like chemotherapy or radiation, ...

Lund University. Immunotherapy harnesses the body’s own immune system to fight disease and has great potential, both in ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...

A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

Jon LaPook, M.D. is the award-winning chief medical correspondent for CBS News. Since joining CBS News in 2006, LaPook has delivered more than 1,200 reports on a wide variety of breaking news and ...

The oncolytic virus immunotherapy market presents opportunities with three approved therapies, extensive clinical trial pipelines, and innovative research by biotechnology and pharmaceutical companies ...

Healthcare professionals may use immunotherapy as part of the treatment for someone with Hodgkin’s lymphoma. They may also use it as part of palliative therapy to improve a person’s quality of life ...

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced ...

At present, only around 5% of patients with colon cancer are candidates for immunotherapy. This new biomarker could make it possible to determine more accurately which individuals may receive this ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...